
The safety and zzso of zzso zzso zzso human zzso zzso have been evaluated in phase I and phase II studies in human patients with a variety of zzso Clinical trials have demonstrated that subcutaneous administration of zzso is safe and well tolerated at doses as high as 5 zzso and as high as 10 zzso when administered 3 zzso Although zzso safety studies in zzso monkeys demonstrated a number of adverse effects following repeated daily dosing with zzso similar effects have generally not been observed in human zzso 

